金达威12月29日获融资买入2620.37万元,融资余额4.79亿元

Core Viewpoint - Jindawei's stock experienced a decline of 2.42% on December 29, with a trading volume of 142 million yuan, indicating a potential shift in investor sentiment and market dynamics [1]. Financing and Margin Trading - On December 29, Jindawei had a financing buy-in amount of 26.20 million yuan and a financing repayment of 27.96 million yuan, resulting in a net financing buy of -1.76 million yuan [1]. - As of December 29, the total margin trading balance for Jindawei was 481 million yuan, with the financing balance at 479 million yuan, accounting for 4.06% of the circulating market value, which is above the 90th percentile level over the past year [1]. - In terms of securities lending, Jindawei repaid 400 shares and sold 200 shares on December 29, with a selling amount of 3,874 yuan, while the remaining securities lending balance was 64,200 shares, valued at 1.24 million yuan, also above the 70th percentile level over the past year [1]. Company Overview - Jindawei Group Co., Ltd. is located in Xiamen, Fujian Province, and was established on November 24, 1997, with its listing date on October 28, 2011 [1]. - The company's main business includes the manufacturing of health food and nutritional products, with revenue composition as follows: health food 54.57%, coenzyme Q10 series 22.04%, other products 11.98%, and vitamin A series 11.41% [1]. Financial Performance - As of September 30, Jindawei had 36,300 shareholders, a decrease of 10.95% from the previous period, while the average circulating shares per person increased by 12.29% to 16,817 shares [2]. - For the period from January to September 2025, Jindawei achieved a revenue of 2.604 billion yuan, representing a year-on-year growth of 11.16%, and a net profit attributable to shareholders of 361 million yuan, reflecting a significant increase of 63.47% [2]. - Since its A-share listing, Jindawei has distributed a total of 2.761 billion yuan in dividends, with 488 million yuan distributed over the past three years [2]. Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the fourth largest circulating shareholder of Jindawei, holding 7.7408 million shares, an increase of 803,600 shares from the previous period [2]. - The Southern CSI 1000 ETF (512100) was the seventh largest circulating shareholder, holding 2.7924 million shares, a decrease of 20,500 shares from the previous period [2]. - The Huaxia CSI 1000 ETF (159845) ranked as the tenth largest circulating shareholder, holding 1.6575 million shares, with a reduction of 4,900 shares from the previous period [2].